QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
NASDAQ:AHCO

AdaptHealth (AHCO) Stock Price, News & Analysis

$7.63
+0.14 (+1.87%)
(As of 02/26/2024 ET)
Today's Range
$7.25
$7.83
50-Day Range
$6.49
$7.85
52-Week Range
$6.37
$22.57
Volume
1.18 million shs
Average Volume
1.02 million shs
Market Capitalization
$1.04 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.64

AdaptHealth MarketRank™ Stock Analysis

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
65.7% Upside
$12.64 Price Target
Short Interest
Bearish
13.96% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.26mentions of AdaptHealth in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$20,972 Sold Last Quarter
Proj. Earnings Growth
22.58%
From $0.62 to $0.76 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.63 out of 5 stars

Medical Sector

258th out of 942 stocks

Home Health Care Services Industry

4th out of 7 stocks


AHCO stock logo

About AdaptHealth Stock (NASDAQ:AHCO)

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

AHCO Stock Price History

AHCO Stock News Headlines

AdaptHealth Q4 2023 Earnings Preview
AdaptHealth (AHCO) Scheduled to Post Quarterly Earnings on Tuesday
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
AdaptHealth (AHCO) Scheduled to Post Earnings on Tuesday
AHCO Mar 2024 10.000 call
AHCO Mar 2024 12.500 put
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
In-Depth Examination Of 4 Analyst Recommendations For AdaptHealth
AHCO NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL,...
See More Headlines
Receive AHCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Today
2/26/2024
Next Earnings (Confirmed)
2/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Home health care services
Sub-Industry
N/A
Current Symbol
NASDAQ:AHCO
Fax
N/A
Employees
10,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.64
High Stock Price Target
$23.00
Low Stock Price Target
$6.50
Potential Upside/Downside
+65.3%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

Net Income
$69.32 million
Pretax Margin
-14.38%

Debt

Sales & Book Value

Annual Sales
$2.97 billion
Cash Flow
$3.17 per share
Book Value
$16.01 per share

Miscellaneous

Free Float
117,841,000
Market Cap
$1.04 billion
Optionable
Optionable
Beta
0.91
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives















AHCO Stock Analysis - Frequently Asked Questions

Should I buy or sell AdaptHealth stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AHCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AHCO, but not buy additional shares or sell existing shares.
View AHCO analyst ratings
or view top-rated stocks.

What is AdaptHealth's stock price target for 2024?

8 brokerages have issued 12-month price objectives for AdaptHealth's stock. Their AHCO share price targets range from $6.50 to $23.00. On average, they predict the company's stock price to reach $12.64 in the next twelve months. This suggests a possible upside of 65.7% from the stock's current price.
View analysts price targets for AHCO
or view top-rated stocks among Wall Street analysts.

How have AHCO shares performed in 2024?

AdaptHealth's stock was trading at $7.29 on January 1st, 2024. Since then, AHCO stock has increased by 4.7% and is now trading at $7.63.
View the best growth stocks for 2024 here
.

When is AdaptHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our AHCO earnings forecast
.

How can I listen to AdaptHealth's earnings call?

AdaptHealth will be holding an earnings conference call on Tuesday, February 27th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were AdaptHealth's earnings last quarter?

AdaptHealth Corp. (NASDAQ:AHCO) issued its quarterly earnings results on Tuesday, November, 7th. The company reported $0.19 earnings per share for the quarter, hitting the consensus estimate of $0.19. The company earned $804.03 million during the quarter, compared to analyst estimates of $796.60 million. AdaptHealth had a negative net margin of 13.68% and a positive trailing twelve-month return on equity of 4.09%. The business's quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the business earned $0.11 EPS.

What other stocks do shareholders of AdaptHealth own?
Who are AdaptHealth's major shareholders?

AdaptHealth's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.74%), Reinhart Partners LLC. (2.98%), Dimensional Fund Advisors LP (1.22%), Royal Bank of Canada (1.17%), Palisade Capital Management LP (1.09%) and Charles Schwab Investment Management Inc. (0.76%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Albert A Prast, Christopher J Joyce, Dale B Wolf, Daniel Bunting, David Solomon Williams III, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Aero Holdings, Llc, Skyknight Capital Fund Ii, LP and Stephen P Griggs.
View institutional ownership trends
.

How do I buy shares of AdaptHealth?

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AHCO) was last updated on 2/26/2024 by MarketBeat.com Staff